144 filings
8-K
CRBP
Corbus Pharmaceuticals Holdings Inc
7 May 24
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
8:30am
8-K
CRBP
Corbus Pharmaceuticals Holdings Inc
10 Apr 24
Departure of Directors or Certain Officers
4:58pm
8-K
CRBP
Corbus Pharmaceuticals Holdings Inc
20 Mar 24
Other Events
5:13pm
8-K
CRBP
Corbus Pharmaceuticals Holdings Inc
12 Mar 24
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
8:15am
8-K
CRBP
Corbus Pharmaceuticals Holdings Inc
6 Feb 24
Departure of Directors or Certain Officers
4:12pm
8-K
1187h8xtqfxwh0e
5 Feb 24
Regulation FD Disclosure
8:12am
8-K/A
18r3yfheofu
1 Feb 24
Financial Statements and Exhibits
8:55pm
8-K
8vf r0wqwjr1
1 Feb 24
Corbus Pharmaceuticals Announces Proposed Public Offering
5:27pm
8-K
w1wp10xdt5 s37fmowq7
31 Jan 24
Other Events
12:00am
8-K
ydal4tv
29 Jan 24
Other Events
7:31am
8-K
b23ax1t
26 Jan 24
Regulation FD Disclosure
7:47am
8-K
bzxx2os5hcavrh 8o42
9 Jan 24
CRB-601 is designed to block the activation of latent TGFβ in the tumor microenvironment
8:45am
8-K
7b2149e287db
14 Nov 23
Regulation FD Disclosure
5:19pm
8-K
5udmq
13 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:25pm
8-K
g3yq52
7 Nov 23
Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
9:23am
8-K
70p0eslkam8lv
8 Aug 23
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
9:05am
8-K
b6updpxh
3 Aug 23
Other Events
8:44am
8-K
avus lb6jdaji72jjfi
19 May 23
Submission of Matters to a Vote of Security Holders
9:01am
8-K
klwj9anz
9 May 23
Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
8:30am
8-K/A
dwk99 c8kehqcknegzt
24 Apr 23
Departure of Directors or Certain Officers
4:39pm